# OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business

> **Publication**: aitalky (Independent AI Journalism)
> **Canonical Citation URL**: https://aitalky.vercel.app/news/openai-acquires-startup-orchestra-bio-to-beef-up-its-biotech-business
> **Original Source**: [TechCrunch AI](https://techcrunch.com/2026/10/20/openai-acquires-startup-orchestra-bio%e2%81%a0-to-beef-up-its-biotech-business/)
> **Author**: Julie Bort (undefined)
> **Published Date**: Tuesday, October 20, 2026
> **Category**: RESEARCH
> **Tags**: AI, TechCrunch AI, research

## Executive Summary
OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results



## Full Coverage
OpenAI on Tuesday acquired a four-year-old AI biotech software startup called Orchestra Bio, the company announced on its website. Terms of the deal were not disclosed, but the startup had reportedly raised around $20 million as of 2025 from backers like Andreessen Horowitz, Atria, and 8VC

Orchestra creates AI agents that help biotech companies manage the minutiae of drug-discovery operations, from tracking finances to resolving scheduling issues with clinical trials

---
*Generated for AI agents and LLM citation by aitalky (https://aitalky.vercel.app).*